A Study of Participants With Squamous Cell Oesophageal Carcinoma Receiving Nivolumab as Part of an Early Access to Medicines Scheme (EAMS) Program in the United Kingdom

Local Institution - 0006, Truro

Local Institution, London

Local Institution, Maidstone

Local Institution, Glasgow

Local Institution, Grimsby

Local Institution, Edinburgh

Local Institution, Birmingham

Local Institution, Leeds

Local Institution, Basingstoke

Local Institution, Bebington

Local Institution, Belfast

Local Institution, Birmingham

Local Institution, Blackburn

Local Institution - 0037, Bristol

Local Institution, Cambridge

Local Institution, Cardiff

Local Institution, Cottingham

Local Institution, Coventry

Local Institution, Derby

Local Institution, Devon

Local Institution, Dundee

Local Institution, Headington

Local Institution, Lancaster

Local Institution, London

Local Institution, London

Local Institution, London

Local Institution, Manchester

Local Institution, Melrose

Local Institution, Northwood

Local Institution, Nottingham

Local Institution, Pembrokeshire

Local Institution, Preston

Local Institution, Surrey

Local Institution, Surrey

Local Institution, Taunton

Local Institution, Walsall